Data Integration Agreement to Improve Workflow in PET Imaging

By MedImaging International staff writers
Posted on 14 Jun 2010
Medrad, Inc. (Warrendale, PA, USA) and Pinestar Technology, Inc. announced plans to enable data communication between Medrad's Intego PET Infusion system and Pinestar Technology Inc.'s (Greenvale, PA, USA) nuclear medicine information system (NMIS). The companies are closing the information gap between state of the art infusion systems and the latest information systems, and thus adding to the workflow benefits of automated fluorodeoxyglucose (FDG) infusion.

The data integration establishes effective communication of PET infusion schedules and histories, and it will be the first of its kind in the market. Large hospitals and even smaller growing PET clinics are challenged to contain costs, reduce errors, and increase their quality of service--even in the face of increasing procedure volumes. Moreover, there is growing interest in electronic medical records across all departments. Therefore, intelligent communication between systems is of utmost importance.

"Integrating the Intego system with NMIS streamlines PET workflow and reduces needless errors, it's what PET clinics are asking for,” said Doug Descalzi, executive director of Medrad's molecular imaging business. "Plus, the integration will compound the workflow benefits that users experience compared to operating the systems independently.”

"Interfacing Intego with Pinestar's NMIS reduces redundant patient demographic entries and transcription errors. Completed dose records are transferred back to the NMIS after the FDG infusion. The technologists will spend more time administering patient care and less time typing,” stated Pinestar president Chet Mody.

Pinestar Technology is a supplier of equipment and accessories in the diagnostic radiology and medical fields and a distributor of medical products and software and manufactures custom-designed table and stretcher pads. Pinestar also develops computer hardware and software serving the medical industry.

Medrad, Inc. develops, markets, and services medical devices used to diagnose and treat disease. Its product range includes fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories, and equipment services.

Related Links:

Medrad
Pinestar Technology



Latest Industry News News